| 1 | [SID26748394] | Active | Potency | 10 | qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4 [AID893, Type: confirmatory] | Chain A, The Structure Of Wild-Type Human Hadh2 (17beta- Hydroxysteroid Dehydrogenase Type 10) Bound [gi:122921310] |  View X | Row No. | 1 | | Structure | 
| | Substance | | | SID | 26748394 | | CID | 853 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4 | | AID | 893 | | BioAssay type | confirmatory | | Target | Chain A, The Structure Of Wild-Type Human Hadh2 (17beta- Hydroxysteroid Dehydrogenase Type 10) Bound [gi:122921310] | | PubMed | | | Data Table | |
|
| 2 | [SID26748394] | Active | Potency | 12.5893 | qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase) [AID887, Type: confirmatory] | 15-lipoxygenase [Homo sapiens] [gi:1832253] | View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 26748394 | | CID | 853 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase) | | AID | 887 | | BioAssay type | confirmatory | | Target | 15-lipoxygenase [Homo sapiens] [gi:1832253] | | PubMed | | | Data Table | |
|
| 3 | [SID26748394] | Active | Potency | 12.5893 | qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase) [AID887, Type: confirmatory] | 15-lipoxygenase [Homo sapiens] [gi:1832253] | View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 26748394 | | CID | 853 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase) | | AID | 887 | | BioAssay type | confirmatory | | Target | 15-lipoxygenase [Homo sapiens] [gi:1832253] | | PubMed | | | Data Table | |
|
| 4 | [SID26748394] | Active | Potency | 15.8489 | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) [AID1030, Type: confirmatory] | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] | View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 26748394 | | CID | 853 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) | | AID | 1030 | | BioAssay type | confirmatory | | Target | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] | | PubMed | | | Data Table | |
|
| 5 | [SID26748394] | Active | Potency | 15.8489 | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) [AID1030, Type: confirmatory] | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] | View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 26748394 | | CID | 853 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) | | AID | 1030 | | BioAssay type | confirmatory | | Target | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] | | PubMed | | | Data Table | |
|
| 6 | [SID103224528] | Active | | | Concentration at which 50% total binding against prealbumin protein occurs [AID161428, Type: Literature] | |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 103224528 | | CID | 853 | | Outcome | Active | | BioAssay | Concentration at which 50% total binding against prealbumin protein occurs | | AID | 161428 | | BioAssay type | Literature | | Target | | | PubMed | 3009810 | | Data Table | |
|
| 7 | [SID48416621] | Active | | | DSSTox (FDAMDD) FDA Maximum (Recommended) Daily Dose Database [AID1195, Type: other] | | View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 48416621 | | CID | 853 | | Outcome | Active | | BioAssay | DSSTox (FDAMDD) FDA Maximum (Recommended) Daily Dose Database | | AID | 1195 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 8 | [SID103224528] | Unspecified | Km | 4.7 | TP_TRANSPORTER: uptake in Xenopus laevis oocytes [AID681174, Type: other] | Monocarboxylate transporter 8 [gi:81871342] | View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 103224528 | | CID | 853 | | Outcome | Unspecified | | Km | 4.7 [uM] | | BioAssay | TP_TRANSPORTER: uptake in Xenopus laevis oocytes | | AID | 681174 | | BioAssay type | other | | Target | Monocarboxylate transporter 8 [gi:81871342] | | PubMed | | | Data Table | |
|
| 9 | [SID103224528] | Unspecified | | | Relative binding affinity to prealbumin was determined from the competition binding assays and is expressed relative to L-T4 [AID161427, Type: Literature] | | View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 103224528 | | CID | 853 | | Outcome | Unspecified | | BioAssay | Relative binding affinity to prealbumin was determined from the competition binding assays and is expressed relative to L-T4 | | AID | 161427 | | BioAssay type | Literature | | Target | | | PubMed | 3009810 | | Data Table | |
|
| 10 | [SID103224528] | Unspecified | | | Major substrate of human cytosolic sulfotransferase SULT4A1_v1 [AID589067, Type: other] | Sulfotransferase 4A1 [gi:22096149] | View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 103224528 | | CID | 853 | | Outcome | Unspecified | | BioAssay | Major substrate of human cytosolic sulfotransferase SULT4A1_v1 | | AID | 589067 | | BioAssay type | other | | Target | Sulfotransferase 4A1 [gi:22096149] | | PubMed | | | Data Table | |
|
| 11 | [SID103224528] | Unspecified | | | Major substrate of human cytosolic sulfotransferase SULT1B1 [AID589060, Type: other] | Sulfotransferase family cytosolic 1B member 1 [gi:57013032] | View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 103224528 | | CID | 853 | | Outcome | Unspecified | | BioAssay | Major substrate of human cytosolic sulfotransferase SULT1B1 | | AID | 589060 | | BioAssay type | other | | Target | Sulfotransferase family cytosolic 1B member 1 [gi:57013032] | | PubMed | | | Data Table | |
|
| 12 | [SID569463] | Unspecified | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model Nontumored Animals (Toxicity Test) in CD2F1 (CDF1) mice [AID188, Type: other] | | View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 569463 | | CID | 853 | | Outcome | Unspecified | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model Nontumored Animals (Toxicity Test) in CD2F1 (CDF1) mice | | AID | 188 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 13 | [SID569463] | Unspecified | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model Nontumored Animals (Toxicity Test) in B6D2F1 (BDF1) mice [AID186, Type: other] | | View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 569463 | | CID | 853 | | Outcome | Unspecified | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model Nontumored Animals (Toxicity Test) in B6D2F1 (BDF1) mice | | AID | 186 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 14 | [SID26748394] | Inactive | Potency | 31.6228 | qHTS Assay for Activators of Cytochrome P450 3A4 [AID885, Type: confirmatory] | cytochrome P450, family 3, subfamily A, polypeptide 4 [Homo sapiens] [gi:13435386] | View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 26748394 | | CID | 853 | | Outcome | Inactive | | Potency | 31.6228 [uM] | | BioAssay | qHTS Assay for Activators of Cytochrome P450 3A4 | | AID | 885 | | BioAssay type | confirmatory | | Target | cytochrome P450, family 3, subfamily A, polypeptide 4 [Homo sapiens] [gi:13435386] | | PubMed | | | Data Table | |
|
| 15 | [SID26748394] | Inactive | Potency | 31.6228 | qHTS Assay for Activators of Cytochrome P450 3A4 [AID885, Type: confirmatory] | cytochrome P450, family 3, subfamily A, polypeptide 4 [Homo sapiens] [gi:13435386] | View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 26748394 | | CID | 853 | | Outcome | Inactive | | Potency | 31.6228 [uM] | | BioAssay | qHTS Assay for Activators of Cytochrome P450 3A4 | | AID | 885 | | BioAssay type | confirmatory | | Target | cytochrome P450, family 3, subfamily A, polypeptide 4 [Homo sapiens] [gi:13435386] | | PubMed | | | Data Table | |
|
| 16 | [SID26748394] | Inactive | Potency | 31.6228 | qHTS Assay for Activators of Cytochrome P450 3A4 [AID885, Type: confirmatory] | cytochrome P450, family 3, subfamily A, polypeptide 4 [Homo sapiens] [gi:13435386] | View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 26748394 | | CID | 853 | | Outcome | Inactive | | Potency | 31.6228 [uM] | | BioAssay | qHTS Assay for Activators of Cytochrome P450 3A4 | | AID | 885 | | BioAssay type | confirmatory | | Target | cytochrome P450, family 3, subfamily A, polypeptide 4 [Homo sapiens] [gi:13435386] | | PubMed | | | Data Table | |
|
| 17 | [SID26748394] | Inactive | Potency | | qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase) [AID1452, Type: confirmatory] | arachidonate 12-lipoxygenase, 12S-type [Homo sapiens] [gi:154426292] | View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 26748394 | | CID | 853 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase) | | AID | 1452 | | BioAssay type | confirmatory | | Target | arachidonate 12-lipoxygenase, 12S-type [Homo sapiens] [gi:154426292] | | PubMed | | | Data Table | |
|
| 18 | [SID26748394] | Inactive | Potency | | qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase) [AID1452, Type: confirmatory] | arachidonate 12-lipoxygenase, 12S-type [Homo sapiens] [gi:154426292] | View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 26748394 | | CID | 853 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase) | | AID | 1452 | | BioAssay type | confirmatory | | Target | arachidonate 12-lipoxygenase, 12S-type [Homo sapiens] [gi:154426292] | | PubMed | | | Data Table | |
|
| 19 | [SID26748394] | Inactive | Potency | | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate [AID2112, Type: confirmatory] | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] | View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 26748394 | | CID | 853 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate | | AID | 2112 | | BioAssay type | confirmatory | | Target | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] | | PubMed | | | Data Table | |
|
| 20 | [SID26748394] | Inactive | Potency | | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate [AID2112, Type: confirmatory] | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] | View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 26748394 | | CID | 853 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate | | AID | 2112 | | BioAssay type | confirmatory | | Target | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] | | PubMed | | | Data Table | |
|
| 21 | [SID26748394] | Inactive | Potency | | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate [AID2112, Type: confirmatory] | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] | View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 26748394 | | CID | 853 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate | | AID | 2112 | | BioAssay type | confirmatory | | Target | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] | | PubMed | | | Data Table | |
|
| 22 | [SID26748394] | Inactive | | | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen [AID2472, Type: screening] | glyceraldehyde-3-phosphate dehydrogenase [Homo sapiens] [gi:7669492] | View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 26748394 | | CID | 853 | | Outcome | Inactive | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen | | AID | 2472 | | BioAssay type | screening | | Target | glyceraldehyde-3-phosphate dehydrogenase [Homo sapiens] [gi:7669492] | | PubMed | | | Data Table | |
|
| 23 | [SID26748394] | Inactive | | | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen [AID2472, Type: screening] | glyceraldehyde-3-phosphate dehydrogenase [Homo sapiens] [gi:7669492] | View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 26748394 | | CID | 853 | | Outcome | Inactive | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen | | AID | 2472 | | BioAssay type | screening | | Target | glyceraldehyde-3-phosphate dehydrogenase [Homo sapiens] [gi:7669492] | | PubMed | | | Data Table | |
|
| 24 | [SID26748394] | Inactive | Potency | | qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease [AID2101, Type: confirmatory] | glucocerebrosidase [Homo sapiens] [gi:496369] | View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 26748394 | | CID | 853 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease | | AID | 2101 | | BioAssay type | confirmatory | | Target | glucocerebrosidase [Homo sapiens] [gi:496369] | | PubMed | | | Data Table | |
|
| 25 | [SID26748394] | Inactive | Potency | | qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease [AID2101, Type: confirmatory] | glucocerebrosidase [Homo sapiens] [gi:496369] | View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 26748394 | | CID | 853 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease | | AID | 2101 | | BioAssay type | confirmatory | | Target | glucocerebrosidase [Homo sapiens] [gi:496369] | | PubMed | | | Data Table | |
|
| 26 | [SID26748394] | Inactive | Potency | | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay [AID995, Type: confirmatory] | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] | View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 26748394 | | CID | 853 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay | | AID | 995 | | BioAssay type | confirmatory | | Target | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] | | PubMed | | | Data Table | |
|
| 27 | [SID26748394] | Inactive | Potency | | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay [AID995, Type: confirmatory] | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] | View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 26748394 | | CID | 853 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay | | AID | 995 | | BioAssay type | confirmatory | | Target | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] | | PubMed | | | Data Table | |
|
| 28 | [SID26748394] | Inactive | Potency | | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay [AID995, Type: confirmatory] | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] | View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 26748394 | | CID | 853 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay | | AID | 995 | | BioAssay type | confirmatory | | Target | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] | | PubMed | | | Data Table | |
|
| 29 | [SID26748394] | Inactive | Potency | | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF [AID1454, Type: confirmatory] | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] | View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 26748394 | | CID | 853 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF | | AID | 1454 | | BioAssay type | confirmatory | | Target | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] | | PubMed | | | Data Table | |
|
| 30 | [SID26748394] | Inactive | Potency | | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF [AID1454, Type: confirmatory] | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] | View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 26748394 | | CID | 853 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF | | AID | 1454 | | BioAssay type | confirmatory | | Target | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] | | PubMed | | | Data Table | |
|
| 31 | [SID26748394] | Inactive | Potency | | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF [AID1454, Type: confirmatory] | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] | View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 26748394 | | CID | 853 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF | | AID | 1454 | | BioAssay type | confirmatory | | Target | mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916] | | PubMed | | | Data Table | |
|
| 32 | [SID26748394] | Inactive | | | qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore) [AID880, Type: confirmatory] | RGS12 [Homo sapiens] [gi:3290016] | View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 26748394 | | CID | 853 | | Outcome | Inactive | | BioAssay | qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore) | | AID | 880 | | BioAssay type | confirmatory | | Target | RGS12 [Homo sapiens] [gi:3290016] | | PubMed | | | Data Table | |
|
| 33 | [SID26748394] | Inactive | Potency | | qHTS Assay for Enhancers of SMN2 Splice Variant Expression [AID1458, Type: confirmatory] | survival motor neuron protein isoform d [Homo sapiens] [gi:10937869] | View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 26748394 | | CID | 853 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Enhancers of SMN2 Splice Variant Expression | | AID | 1458 | | BioAssay type | confirmatory | | Target | survival motor neuron protein isoform d [Homo sapiens] [gi:10937869] | | PubMed | | | Data Table | |
|
| 34 | [SID26748394] | Inactive | Potency | | qHTS Assay for Enhancers of SMN2 Splice Variant Expression [AID1458, Type: confirmatory] | survival motor neuron protein isoform d [Homo sapiens] [gi:10937869] | View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 26748394 | | CID | 853 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Enhancers of SMN2 Splice Variant Expression | | AID | 1458 | | BioAssay type | confirmatory | | Target | survival motor neuron protein isoform d [Homo sapiens] [gi:10937869] | | PubMed | | | Data Table | |
|
| 35 | [SID26748394] | Inactive | Potency | | Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 [AID1479, Type: confirmatory] | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] | View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 26748394 | | CID | 853 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 | | AID | 1479 | | BioAssay type | confirmatory | | Target | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] | | PubMed | | | Data Table | |
|
| 36 | [SID26748394] | Inactive | Potency | | Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 [AID1479, Type: confirmatory] | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] | View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 26748394 | | CID | 853 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 | | AID | 1479 | | BioAssay type | confirmatory | | Target | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] | | PubMed | | | Data Table | |
|
| 37 | [SID26748394] | Inactive | Potency | | Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 [AID1479, Type: confirmatory] | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] | View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 26748394 | | CID | 853 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 | | AID | 1479 | | BioAssay type | confirmatory | | Target | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] | | PubMed | | | Data Table | |
|
| 38 | [SID26748394] | Inactive | Potency | | qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 [AID1469, Type: confirmatory] | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] | View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 26748394 | | CID | 853 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 | | AID | 1469 | | BioAssay type | confirmatory | | Target | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] | | PubMed | | | Data Table | |
|
| 39 | [SID26748394] | Inactive | Potency | | qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 [AID1469, Type: confirmatory] | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] | View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 26748394 | | CID | 853 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 | | AID | 1469 | | BioAssay type | confirmatory | | Target | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] | | PubMed | | | Data Table | |
|
| 40 | [SID26748394] | Inactive | Potency | | qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 [AID1469, Type: confirmatory] | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] | View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 26748394 | | CID | 853 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 | | AID | 1469 | | BioAssay type | confirmatory | | Target | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] | | PubMed | | | Data Table | |
|
| 41 | [SID26748394] | Inactive | Potency | | qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature [AID924, Type: confirmatory] | cellular tumor antigen p53 isoform a [Homo sapiens] [gi:120407068] | View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 26748394 | | CID | 853 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature | | AID | 924 | | BioAssay type | confirmatory | | Target | cellular tumor antigen p53 isoform a [Homo sapiens] [gi:120407068] | | PubMed | | | Data Table | |
|
| 42 | [SID26748394] | Inactive | Potency | | qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature [AID924, Type: confirmatory] | cellular tumor antigen p53 isoform a [Homo sapiens] [gi:120407068] | View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 26748394 | | CID | 853 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature | | AID | 924 | | BioAssay type | confirmatory | | Target | cellular tumor antigen p53 isoform a [Homo sapiens] [gi:120407068] | | PubMed | | | Data Table | |
|
| 43 | [SID26748394] | Inactive | Potency | | qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature [AID924, Type: confirmatory] | cellular tumor antigen p53 isoform a [Homo sapiens] [gi:120407068] | View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 26748394 | | CID | 853 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature | | AID | 924 | | BioAssay type | confirmatory | | Target | cellular tumor antigen p53 isoform a [Homo sapiens] [gi:120407068] | | PubMed | | | Data Table | |
|
| 44 | [SID26748394] | Inactive | Potency | | qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature [AID924, Type: confirmatory] | cellular tumor antigen p53 isoform a [Homo sapiens] [gi:120407068] | View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 26748394 | | CID | 853 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature | | AID | 924 | | BioAssay type | confirmatory | | Target | cellular tumor antigen p53 isoform a [Homo sapiens] [gi:120407068] | | PubMed | | | Data Table | |
|
| 45 | [SID26748394] | Inactive | Potency | | qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature [AID902, Type: confirmatory] | cellular tumor antigen p53 isoform a [Homo sapiens] [gi:120407068] | View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 26748394 | | CID | 853 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature | | AID | 902 | | BioAssay type | confirmatory | | Target | cellular tumor antigen p53 isoform a [Homo sapiens] [gi:120407068] | | PubMed | | | Data Table | |
|
| 46 | [SID26748394] | Inactive | Potency | | qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature [AID902, Type: confirmatory] | cellular tumor antigen p53 isoform a [Homo sapiens] [gi:120407068] | View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 26748394 | | CID | 853 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature | | AID | 902 | | BioAssay type | confirmatory | | Target | cellular tumor antigen p53 isoform a [Homo sapiens] [gi:120407068] | | PubMed | | | Data Table | |
|
| 47 | [SID26748394] | Inactive | Potency | | qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature [AID902, Type: confirmatory] | cellular tumor antigen p53 isoform a [Homo sapiens] [gi:120407068] | View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 26748394 | | CID | 853 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature | | AID | 902 | | BioAssay type | confirmatory | | Target | cellular tumor antigen p53 isoform a [Homo sapiens] [gi:120407068] | | PubMed | | | Data Table | |
|
| 48 | [SID26748394] | Inactive | Potency | | qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature [AID902, Type: confirmatory] | cellular tumor antigen p53 isoform a [Homo sapiens] [gi:120407068] | View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 26748394 | | CID | 853 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature | | AID | 902 | | BioAssay type | confirmatory | | Target | cellular tumor antigen p53 isoform a [Homo sapiens] [gi:120407068] | | PubMed | | | Data Table | |
|
| 49 | [SID26748394] | Inactive | Potency | | qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1: Spectroscopic Profiling in AFC Spectral Region [AID923, Type: confirmatory] | | View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 26748394 | | CID | 853 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1: Spectroscopic Profiling in AFC Spectral Region | | AID | 923 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table | |
|
| 50 | [SID569463] | Inactive | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice [AID248, Type: other] | | View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 569463 | | CID | 853 | | Outcome | Inactive | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice | | AID | 248 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
Chemical Probe 
Active 
Inactive 
Inconclusive 
Unspecified 
